SOHO 2023
SOHO 2023
Advertisement
Patrick DalySOHO 2023 | September 14, 2023
Patients with ibrutinib dose reduction after an AE had longer treatment length and similar efficacy versus no dose reduction.
Read More
Patrick DalySOHO 2023 | September 14, 2023
A study on patterns in patients with CLL found the RFC regimen appeared to be most effective for OS and response rates.
Patrick DalySOHO 2023 | September 14, 2023
Patients with chronic lymphocytic leukemia experience more anxiety when receiving intravenous versus oral treatments.
Patrick DalySOHO 2023 | September 14, 2023
Patients with CLL who relapsed after HSCT and then received venetoclax therapy achieved outcomes consistent with trial data.
Advertisement
Advertisement
Advertisement
Latest News

June 19, 2024